- SPANNR
- Posts
- Issue #40
Issue #40
Issue #40
March 2, 2023 | Issue #40
Good evening. Welcome back to another issue of Spannr.In this week's newsletter:š Your summer reading listāļø TruDiagnostic claps back at trending DNAm age testsš¢ This week's funding announcements
The Top Books On Longevity
Fortunately, you donāt have to be an awarded biologist or health connoisseur to fathom the intriguing field of longevity and everything it has to offer.There are now countless resources available to help laymen sort through the noise, from compelling documentaries to fascinating longevity podcasts.Books, however, remain one of the more effective mediums for learning about any nascent industry.Longevity books offer wisdom from some of the brightest experts, researchers, and scientists in the field. They provide depth, history, and compile observations from decadesā worth of clinical research.If youāre looking for a foundational step into the field of longevity, look no further.āāTo help get you started, here are some of the best longevity books this growing niche has to offer.
Five Alarm Bio, focused on minimizing the effects of aging in humans, raises over Ā£500K GBP in a seed investment round with participation from Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, and angel investors
Chroma Medicine secures $135 million in Series B financing to advance breakthrough epigenetic editing technology led by Google Ventures, with participation from ARCH Venture Partners, DCVC Bio, Mubadala Capital, Sixth Street, and existing investors
Thymmune Therapeutics, a biotechnology company developing scalable thymic cell therapies to restore immune function in aging and disease, announced today that it has secured $7 million in seed financing led by Pillar VC, with participation from NYBC Ventures and other investors
Causeway Therapeutics, a University of Glasgow spin-out, raises Ā£8.75 million from investors to conduct an international phase two clinical trial of its lead compound, TenoMIR in lateral epicondylitis, commonly referred to as tennis elbow.
Bioinformatician at TruDiagnostic slams new aging test manufacturers, including the newly launched Tally (Varun Dwaraka)
The Next Fountain-of-Youth Craze? Peptide Injections (WSJ)
Can We Change How Fast Humans Age? A New Study Is Getting Closer to the Answer (Inverse)
Robust Mouse Rejuvenation Study finally started last week (LEV Foundation)
Japan births fall to record low as population crisis deepens (CNN)
Three-parent baby technique could create babies at risk of severe disease (Technology Review)
BetterHelp Barred by FTC From Sharing Data With Facebook (Bloomberg)
Is reverse aging already possible? Drugs that could treat aging might already be on the pharmacy shelves (Fortune)
When 65 is Young: The Politics of Life Extension (Jamie Paul)
Performance:
Latest Price: $116.647d-Return: -3.86%Market Cap: $11.95b